Next Article in Journal
Cellular and Molecular Preconditions for Retinal Pigment Epithelium (RPE) Natural Reprogramming during Retinal Regeneration in Urodela
Next Article in Special Issue
Nano-Magnetic Resonance Imaging (Nano-MRI) Gives Personalized Medicine a New Perspective
Previous Article in Journal / Special Issue
The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials
Article Menu

Export Article

Open AccessReview
Biomedicines 2016, 4(4), 27; doi:10.3390/biomedicines4040027

Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets

1
Integrative Biology, Baylor College of Medicine, Houston, TX 77030, USA
2
School of Biological Sciences, Indian Institute of Technology, Delhi 110016, India
3
Department of Pharmaceutics and Pharmaceutical Microbiology, Usmanu Danfodiyo University, Sokoto 840231, Nigeria
4
Experimental Cardiovascular Research Unit, Department of Medicine-Solna, Center for Molecular Medicine, Karolinska Institute, Stockholm 17177, Sweden
*
Author to whom correspondence should be addressed.
Academic Editor: Benjamin Franc
Received: 30 August 2016 / Revised: 16 November 2016 / Accepted: 17 November 2016 / Published: 21 November 2016
(This article belongs to the Special Issue Molecular Imaging as a Tool for Personalized Medicine)
View Full-Text   |   Download PDF [2750 KB, uploaded 21 November 2016]   |  

Abstract

In the past decade, it was observed that the relationship between the emerging New Molecular Entities and the quantum of R&D investment has not been favorable. There might be numerous reasons but few studies stress the introduction of target based drug discovery approach as one of the factors. Although a number of drugs have been developed with an emphasis on a single protein target, yet identification of valid target is complex. The approach focuses on an in vitro single target, which overlooks the complexity of cell and makes process of validation drug targets uncertain. Thus, it is imperative to search for alternatives rather than looking at success stories of target-based drug discovery. It would be beneficial if the drugs were developed to target multiple components. New approaches like reverse engineering and translational research need to take into account both system and target-based approach. This review evaluates the strengths and limitations of known drug discovery approaches and proposes alternative approaches for increasing efficiency against treatment. View Full-Text
Keywords: drug discovery; drug design; drug targets; repositioning; molecular imaging drug discovery; drug design; drug targets; repositioning; molecular imaging
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Vasaikar, S.; Bhatia, P.; Bhatia, P.G.; Chu Yaiw, K. Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets. Biomedicines 2016, 4, 27.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top